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Abstract
Leprosy is a chronic infection caused by Mycobacterium leprae, a bacillus that presents a peculiar tropism for the skin 
and peripheral nerves. The clinical spectrum of leprosy ranges from the tuberculoid form (TT) to the disseminative 
and progressive lepromatous form (LL). Oral lesions are rare but, when present, occur in the lepromatous form. This 
article describes the clinical and microscopic findings of three cases of LL with oral manifestations. All patients 
had the lepromatous form and their leprosy-specific oral lesions occurred in the palate. The diagnosis was based on 
clinical, serological and histopathological findings, and multidrug therapy for multibacillary leprosy was started and 
continued for 24 months. All patients completed treatment, but developed reaction episodes which were treated with 
prednisone and/or thalidomide. The authors emphasize the importance of oral mucosa evaluation by a dental health 
professional during patient care since oral lesions may act as a source of infection.
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Introduction
Leprosy is a chronic infectious disease caused by Mycobac-
terium leprae, an acid-fast bacillus that presents a peculiar 
tropism for the skin and peripheral nerves. Leprosy is still 
a public health problem in many parts of the world.  In 
2006, the number of new cases detected fell globally when 
compared with 2005. However, Brazil still represents an 
important part of the global burden of the disease in the 
Americas (1).
Leprosy presents a clinical spectrum ranging from the 
tuberculoid form (TT), with lesions that are often self-
healing, to the disseminate and progressive lepromatous 
form (LL). Within this spectrum there are borderline forms 
with intermediate lesions between the 2 polar forms (2). Oral 
lesions are uncommon in leprosy but when present occur in 
patients with the LL form (3-8). These lesions are generally 
asymptomatic ulcers or nodules sometimes rich in M. leprae 
(6,9,10) resembling nonspecific oral lesions. However they 
can maintain the focus of infection in endemic areas. 
This article describes the oral lesions of leprosy of 3 LL 
patients, and alerts physicians to the importance of oral 
mucosa evaluation during patient care.
Case Reports
- Patients. The demographic data, clinical information, 
laboratory features, treatment and outcome of 3 patients 
with leprosy with oral manifestations were reviewed and 
are described here. All cases were retrieved from the files 
of the University Hospital of the Faculty of Medicine of 
Ribeirao Preto, Sao Paulo University (Brazil). 
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Fig. 1. Clinical presentation of patients: skin infiltration giving rise to 
the leonine facies (1a); oral ulcer in the hard and soft palate (1b and 
1h); resolution of oral lesions after MDT (1c and 1f); nodules on the 
ear (1d); ulceration with granulomatous surface in the soft palate (1e); 
papules and nodules on the hands (1g).
Fig. 2. Histopathological findings of the three patients reported: pho-
tomicrograph of skin lesions showing an atrophic epidermis with loss 
of the rete ridges. The papillary dermis appears as a clear band, and the 
deeper dermis is infiltrated with chronic inflammatory cells. Hematoxylin 
and eosin x100 (2a), and fite-faraco x200 (2d). Photomicrograph of oral 
lesions showing dense mononuclear inflammation with the presence 
of histiocytes with foamy cytoplasm vacuoles. Hematoxylin and eosin 
x200 (2b and 2i). Histiocytes with large amounts of acid-fast bacilli 
compatible with M. leprae. Fite-faraco x1000 (2c, 2e, 2h and 2j), and 
epithelial hyperplasia with areas of  ulceration and a dense lympho-
histiocytic inflammatory infiltrate. Hematoxylin and eosin x100 (2f), 
fite-faraco x100 (2g). 
- Clinical findings. At the time of diagnosis, patient age 
ranged from 39 to 55. All patients were male rural wor-
kers, one of them white and two African-American. They 
presented skin and mucosal lesions as shown in Figure 1, 
and were classified as having LL (11). Mucosal disease was 
found in the palate and nasal mucosa in all cases. The soft 
palate was affected in all cases and the hard palate in two 
(Figures 1b, 1e and 1h) (Table 1).
- Laboratory features. Complementary tests for the 
diagnosis of  leprosy were the Mitsuda reaction (MR), 
bacilloscopy, biopsy, and the determination of antibodies 
to phenolic glycolipid I (anti-PGL1) (Table 1). MR was 
negative in all patients, whereas bacilloscopy was positive 
in all of them. Histopathologic examination of the skin 
showed an atrophic epidermis with loss of the rete ridges 
in all patients; the papillary dermis appeared as a clear 
band, and the deeper dermis was infiltrated with chronic 
inflammatory cells (Figures 2a, 2d and 2h). Examination 
of the oral lesions showed epithelial hyperplasia with areas 
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of ulceration and a dense lymphohistiocytic inflammatory 
infiltrate with the presence of histiocytes showing foamy 
cytoplasm vacuoles with large amounts of acid-fast ba-
cilli in all patients (Figures 2b, 2c, 2e, 2f, 2g, 2i and 2j). 
High levels of anti-PGL1 antibodies were detected in all 
patients (Table 1).
- Treatolipid 1.ment and outcome. Patients were treated 
with multidrug therapy for multibacillary leprosy consis-
ting of 600 mg rifampicin daily, 300 mg clofazimine once 
a month/50 mg daily, and 100 mg dapsone  daily, for a 
total of 24 doses. All patients completed treatment with 
resolution of their leprosy-specific skin and oral lesions 
(Figures 1c and 1f). However, they developed reaction 
episodes (erythema nodosum) during the treatment of 
leprosy, so they needed to be treated prednisone and/or 
thalidomide. All three patients are currently free of oral 
leprosy lesions.
Discussion
The upper airways are the main point of entry for the 
bacillus and a route for bacillary elimination in leprosy 
(9,12,13). For this reason, the control of mucosal lesions 
is very important. Mucosal involvement is particularly 
outstanding in the nose, probably due to the preference 
of M. leprae for cooler sites (10,12,13). 
Oral lesions usually appear as ulcerations of the hard or 
soft palate (3,4,8), as observed in our 3 cases. However, 
they can affect any other site, including the tongue (5,9). 
In addition, these lesions may be nodular and ulcerated, 
as observed in patient 1. In general, oral involvement only 
appears in the advanced stages of LL, suggesting hemato-
genous or lymphatic dissemination of M. leprae (13). Two 
of our patients reported that they had noticed the disease 
one year before, a fact possibly indicating a delayed diag-
nosis since these patients presented the LL form.
Another possibility for the development of oral lesions is 
continuity, with nasal lesions possibly being precursors of 
oral lesions (3,9). Local treatment such as a mouthwash 
with antimicrobial solutions may be offered to reduce the 
risk of secondary infection. But it is unsatisfactory unless 
leprosy-specific treatment is instituted. All patients had 
nasal and oral lesions, with the latter being limited to soft 
tissues. Therefore, this suggests the occurrence of hemato-
genous dissemination rather than lesion by continuity. 
The present findings suggest that the route of transmission 
may increase in endemic areas when the oral mucosa is 
affected, since viable bacilli have been detected at these 
sites (9). Thus, patient examination should be extended to 
the oral mucosa because in advanced leprosy the mouth 
can acquire the characteristics of a reservoir of bacilli, and 
thus may act as an important risk factor for transmission 
of the illness. 
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